BRIEF-Enteris Biopharma enters agreement with Sanofi to develop investigational oral therapeutic for type 2 diabetes

* Enteris Biopharma enters agreement with Sanofi to develop investigational oral therapeutic for type 2 diabetes Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.